Already a member? Click here to login.
Already a member? Click here to login.
From 1 March 2022, the Dexcom G5 Mobile CGM system (Dexcom G5 Mobile sensor and transmitter products) will be removed from the range of devices available through the CGM Initiative as part of the NDSS and will no longer be available through NDSS Access Points.
The delisting of Dexcom G5 follows the announcement by AMSL Diabetes that it is discontinuing sales of Dexcom G5 products in Australia.
Health professionals are requested to not initiate any new starters or change of device forms to Dexcom G5 prior to the delisting.
To coincide with the delisting of Dexcom G5, from 1 March 2022, the Dexcom G6 CGM system will be available through the NDSS to all people who meet the CGM Initiative eligibility criteria.
Note: Dexcom G6 products have been available to access through the CGM Initiative on a limited basis for Tandem t:slim X2 insulin pump users only since 18 January 2021. From 1 March 2022, this restriction will be removed and Dexcom G6 will be available to all people who meet the CGM Initiative eligibility criteria and choose this device in consultation with their diabetes health professional.
In order to ensure that access to CGM products and continuity of care is maintained for users of Dexcom G5, the NDSS is supporting people with diabetes through the change to a replacement device.
Users of Dexcom G5, accessed through the CGM Initiative, will be automatically updated to Dexcom G6 on 1 March 2022. There is no requirement for these people to see their diabetes health professional. However, if people have concerns, questions or require assistance transitioning to the new device, or wish to discuss using an alternate device, they should make an appointment with their diabetes health professional as soon as possible.
No Starter Kit is required for users of Dexcom G5 automatically transitioning to Dexcom G6. However, people should consult their diabetes health professional if they have concerns or require assistance transitioning to the new device.
The eligibility criteria to access CGM and flash glucose monitoring products through the CGM Initiative have not changed.
From 1 March 2022, updated Continuous and Flash Glucose Monitoring Access forms will be available on the NDSS website at ndss.com.au/forms#cgm.
Only health professionals listed on the Continuous and Flash Glucose Monitoring Access forms can certify access.
More information is available on the NDSS website at ndss.com.au/changes-to-the-ndss-for-health-professionals.
From 1 March 2022, the Dexcom G5 Mobile CGM system (Dexcom G5 Mobile sensor and transmitter products) will be removed from the range of devices available through the CGM Initiative as part of the NDSS and will no longer be available through NDSS Access Points.
The delisting of Dexcom G5 follows the announcement by AMSL Diabetes that it is discontinuing sales of Dexcom G5 products in Australia.
Health professionals are requested to not initiate any new starters or change of device forms to Dexcom G5 prior to the delisting.
To coincide with the delisting of Dexcom G5, from 1 March 2022, the Dexcom G6 CGM system will be available through the NDSS to all people who meet the CGM Initiative eligibility criteria.
Note: Dexcom G6 products have been available to access through the CGM Initiative on a limited basis for Tandem t:slim X2 insulin pump users only since 18 January 2021. From 1 March 2022, this restriction will be removed and Dexcom G6 will be available to all people who meet the CGM Initiative eligibility criteria and choose this device in consultation with their diabetes health professional.
In order to ensure that access to CGM products and continuity of care is maintained for users of Dexcom G5, the NDSS is supporting people with diabetes through the change to a replacement device.
Users of Dexcom G5, accessed through the CGM Initiative, will be automatically updated to Dexcom G6 on 1 March 2022. There is no requirement for these people to see their diabetes health professional. However, if people have concerns, questions or require assistance transitioning to the new device, or wish to discuss using an alternate device, they should make an appointment with their diabetes health professional as soon as possible.
No Starter Kit is required for users of Dexcom G5 automatically transitioning to Dexcom G6. However, people should consult their diabetes health professional if they have concerns or require assistance transitioning to the new device.
The eligibility criteria to access CGM and flash glucose monitoring products through the CGM Initiative have not changed.
From 1 March 2022, updated Continuous and Flash Glucose Monitoring Access forms will be available on the NDSS website at ndss.com.au/forms#cgm.
Only health professionals listed on the Continuous and Flash Glucose Monitoring Access forms can certify access.
More information is available on the NDSS website at ndss.com.au/changes-to-the-ndss-for-health-professionals.
